Addendum for '06 report: FY05 LDRD-ER, FY06 Report, Rapid Defense Against the Next-Generation Biothreat
Prior to using human nasopharyngeal samples, we will use prepared mixtures of viruses with bacteria and eukaryotic cells in our research on microfluidic separation techniques. Some examples of these mixtures are the bacteriophage MS2 with its host bacteria, E. coli, and BSL-1, Risk-Group-1 virus such as fowlpox virus vaccine with its host cell, DF-1, derived from chickens.
- Research Organization:
- Lawrence Livermore National Laboratory (LLNL), Livermore, CA
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- W-7405-ENG-48
- OSTI ID:
- 1016926
- Report Number(s):
- UCRL-TR--227807
- Country of Publication:
- United States
- Language:
- English
Similar Records
A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets
High-yield production of a stable Vero cell-based vaccine candidate against the highly pathogenic avian influenza virus H5N1
Affinity selection of Nipah and Hendra virus-related vaccine candidates from a complex random peptide library displayed on bacteriophage virus-like particles
Journal Article
·
Fri Aug 15 00:00:00 EDT 2008
· Virology
·
OSTI ID:21141027
High-yield production of a stable Vero cell-based vaccine candidate against the highly pathogenic avian influenza virus H5N1
Journal Article
·
Fri May 18 00:00:00 EDT 2012
· Biochemical and Biophysical Research Communications
·
OSTI ID:22207862
Affinity selection of Nipah and Hendra virus-related vaccine candidates from a complex random peptide library displayed on bacteriophage virus-like particles
Patent
·
Mon Jan 23 23:00:00 EST 2017
·
OSTI ID:1340588